Myers Scott Dunseth

Myers Scott Dunseth is listed in filings as Director at Dynavax Technologies Corporation. This profile follows SEC Form 4 activity through Feb 10, 2026, including purchase activity. Recent filings connect the profile to Dynavax Technologies Corporation (DVAX) and Zentalis Pharmaceuticals, Inc. (ZNTL). The current snapshot covers public activity from Nov 13, 2024 to Feb 10, 2026. Reported amounts are shown as $789.8K to $266.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.